11.16.20

Horizon: New Data Build on Growing Evidence Supporting Tepezza Efficacy in Thyroid Eye Disease (TED)

Source: Horizon Therapeutics

11.16.20

Innovent Announces the Results of the Phase 1 Clinical Trial of IBI302 for Wet AMD at AAO 2020

Source: Innovent Biologics

11.16.20

EyePoint Pharmaceuticals Presents Positive Data of Yutiq and Dexycu in Four Poster Sessions at AAO 2020

Source: EyePoint Pharmaceuticals

11.16.20

Late-Breaking 12-Month Data of Investigational RPGR Gene Therapy Shows Statistically Significant and Continued Vision Improvement in Patients with XLRP

11.16.20

Clearside Biomedical Announces Data Presentations at the AAO 2020

Source: Clearside Biomedical

11.16.20

iSTAR Medical’s Glaucoma Device MINIject Shows Positive One-Year Results in European Trial

Source: iSTAR Medical

11.13.20

Oyster Point Pharma Announces Clinical Data Presentations on OC-01 Nasal Spray for Dry Eye Disease at AAO Virtual

Source: Oyster Point Pharma

11.13.20

Apellis Announces Late-Breaking Presentation of Largest Retrospective Database Study in Geographic Atrophy at AAO 2020 Virtual

Source: Apellis Pharmaceuticals

11.13.20

Gemini Therapeutics Announces GEM103 Meets All Endpoints in Phase 1 Clinical Study

Source: Gemini Therapeutics

11.13.20

Nanoscope Therapeutics Announces Presentation at the 2020 AAO

Source: Nanoscope Therapeutics

View more stories